NO972477L - Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse - Google Patents

Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse

Info

Publication number
NO972477L
NO972477L NO972477A NO972477A NO972477L NO 972477 L NO972477 L NO 972477L NO 972477 A NO972477 A NO 972477A NO 972477 A NO972477 A NO 972477A NO 972477 L NO972477 L NO 972477L
Authority
NO
Norway
Prior art keywords
meso
mono
preparation
methods
iodine substituted
Prior art date
Application number
NO972477A
Other languages
English (en)
Other versions
NO310111B1 (no
NO972477D0 (no
Inventor
Ross W Boyle
David Dolphin
Claire K Johnson
Original Assignee
Quadra Logic Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quadra Logic Tech Inc filed Critical Quadra Logic Tech Inc
Publication of NO972477D0 publication Critical patent/NO972477D0/no
Publication of NO972477L publication Critical patent/NO972477L/no
Publication of NO310111B1 publication Critical patent/NO310111B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO19972477A 1994-12-02 1997-05-30 Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse NO310111B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/349,179 US5703230A (en) 1994-12-02 1994-12-02 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same
PCT/CA1995/000668 WO1996016966A1 (en) 1994-12-02 1995-11-27 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same

Publications (3)

Publication Number Publication Date
NO972477D0 NO972477D0 (no) 1997-05-30
NO972477L true NO972477L (no) 1997-07-11
NO310111B1 NO310111B1 (no) 2001-05-21

Family

ID=23371232

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972477A NO310111B1 (no) 1994-12-02 1997-05-30 Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse

Country Status (14)

Country Link
US (1) US5703230A (no)
EP (1) EP0794954A1 (no)
JP (1) JPH10509733A (no)
KR (1) KR987000306A (no)
CN (1) CN1069319C (no)
AU (1) AU700299B2 (no)
CA (1) CA2205366C (no)
CZ (1) CZ146197A3 (no)
FI (1) FI972245A (no)
HU (1) HUT77552A (no)
NO (1) NO310111B1 (no)
NZ (1) NZ295619A (no)
PL (1) PL320513A1 (no)
WO (1) WO1996016966A1 (no)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000052012A2 (en) 1999-03-05 2000-09-08 Emory University A method for synthesizing porphyrin compounds
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
WO2001078606A1 (en) * 2000-04-12 2001-10-25 Trustees Of Boston University Selective nuclear receptor-targeted systems for delivery of cytotoxins to cancer cells for targeted photodynamic therapy
CA2408332C (en) 2000-05-08 2011-02-15 The University Of British Columbia Supports for photosensitizer formulations
AU2001258095A1 (en) * 2000-05-08 2001-11-20 The University Of British Columbia Drug delivery systems for photodynamic therapy
EP1197229A1 (en) * 2000-10-13 2002-04-17 Boston Clinics PDT B.V. Method of inactivating microorganisms
EP1401430A4 (en) * 2001-05-31 2005-10-19 Miravant Pharm Inc SUBSTITUTED PORPHYRIN AND AZAPORPHYRIN DERIVATIVES AND USE IN PHOTODYNAMIC THERAPY, RADIOIMAGING, AND MRI DIAGNOSIS
EP1443964B1 (en) * 2001-11-09 2008-02-20 QLT Inc. Photodynamic therapy for the treatment of hair loss
EP1517684B1 (en) 2002-06-27 2009-07-22 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CA2513133A1 (en) * 2003-01-16 2004-07-29 Techno Mart Co., Ltd. Porphyrin derivatives
WO2004098629A1 (en) * 2003-05-12 2004-11-18 Yeda Research And Development Co. Ltd. GnRH CONJUGATES COMPRISING A PHOTOSENSITIZER FOR PHOTODYNAMIC THERAPY
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
KR100681911B1 (ko) * 2006-04-03 2007-02-15 재단법인서울대학교산학협력재단 5,10,15,20―테트라키스―（2―플루오로―피리딘―3―일）―포르피린,5,10,15,20―테트라키스―（3,5―다이플루오로―피리딘―4―일）―포르피린과 이들의 ｎ―알킬염 및 이들의 제조방법
US20070299046A1 (en) * 2006-06-26 2007-12-27 Mai Nguyen Brooks Orally available light-independent antineoplastic compounds
ES2932287T3 (es) * 2008-09-18 2023-01-17 Biolitec Unternehmensberatungs Ii Ag Método y aplicación novedosos de porfirinas y clorinas meso-sustituidas asimétricamente para TFD
US9226917B2 (en) 2008-12-16 2016-01-05 Valeant Pharmaceuticals International, Inc. Photodynamic therapy for conditions of the eye
US9113535B2 (en) 2010-06-30 2015-08-18 The University Of Southern California Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications
US10256421B2 (en) 2010-06-30 2019-04-09 University Of Southern California Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications
CN108752354A (zh) * 2018-06-11 2018-11-06 三峡大学 一种卟啉荧光染料的合成及其方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252720A (en) * 1989-03-06 1993-10-12 Board Of Regents, The University Of Texas System Metal complexes of water soluble texaphyrins

Also Published As

Publication number Publication date
KR987000306A (ko) 1998-03-30
MX9703932A (es) 1998-05-31
US5703230A (en) 1997-12-30
EP0794954A1 (en) 1997-09-17
PL320513A1 (en) 1997-10-13
HUT77552A (hu) 1998-05-28
FI972245A (fi) 1997-07-16
AU700299B2 (en) 1998-12-24
CA2205366C (en) 2002-11-05
NO310111B1 (no) 2001-05-21
CN1069319C (zh) 2001-08-08
WO1996016966A1 (en) 1996-06-06
NO972477D0 (no) 1997-05-30
NZ295619A (en) 1999-05-28
FI972245A0 (fi) 1997-05-28
CN1172485A (zh) 1998-02-04
AU3920595A (en) 1996-06-19
JPH10509733A (ja) 1998-09-22
CZ146197A3 (en) 1997-10-15
CA2205366A1 (en) 1996-06-06

Similar Documents

Publication Publication Date Title
NO972477L (no) Meso-mono-jod substituerte tetramakrocykliske forbindelser og fremgangsmåter for fremstilling og anvendelse
NO972125L (no) Hemorroideblandinger og fremgangsmåte for anvendelse
NO954239L (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO974572D0 (no) Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav
MX9200273A (es) Nuevos compuestos de sulfonilureas y procedimientopara su obtencion
NO20003067L (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO914315D0 (no) Fremgangsmaate og sammensetning for surgjoering av underjordiske formasjoner
NO20003070D0 (no) Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav
ID18679A (id) Penggunaan terapi lanjutan
DK1003383T4 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
NO932282D0 (no) Oljeaktig preparat og fremgangsmaate for fremstilling av dette
NO990913D0 (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
NO940634L (no) Antiulcusmiddel og fremgangsmåte for fremstilling derav
NO952261D0 (no) Antacidiumforbindelser og fremgangsmåte for fremstilling derav
NO20012099L (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- karbinoler og beslektede forbindelser
KR970701546A (ko) 퀴놀린-3-카르복사미드 화합물의 새로운 용도(new use of quinoline-3-carboxamide compounds)
FI972055A (fi) Syljen analysointimenetelmä
NO932638L (no) 21-klor-pregnanderivat og fremgangsmaater for dets fremstilling
UA26923C2 (uk) Спосіб одержаhhя феромагhітhого порошку
KR960019927U (ko) 사용이 용이하도록 한 젓가락
LV10947A (lv) Piroglutaminskabes 4-metilkumaril-7-amida iegusanas metode
NO944386L (no) Fremstilling og anvendelse av tetrazolderivater
UA644S (uk) Мікро-еом широкого призначення
NO923358L (no) Fremgangsmaate for fremstilling av antihyperkolesterolemiske tetrazolforbindelser og mellomprodukter derav

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003